Point72 Asset Management, L.P. - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2021$3,693,000
-3.7%
461,000
+0.7%
0.02%
-11.8%
Q3 2021$3,833,000
-61.9%
457,900
-69.9%
0.02%
-63.8%
Q1 2021$10,059,000
+502850.0%
1,521,800
+1521700.0%
0.05%
Q2 2015$2,000
-96.4%
100
-96.0%
0.00%
Q1 2015$55,0002,5000.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2021
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$18,010,7836.83%
M28 Capital Management LP 1,910,600$7,069,2206.74%
Opaleye Management Inc. 1,460,000$5,402,0001.88%
Ikarian Capital, LLC 422,625$1,563,7130.38%
Monaco Asset Management SAM 165,000$610,5000.18%
AWM Investment Company, Inc. 166,667$616,6680.09%
FRANKLIN STREET ADVISORS INC /NC 150,000$5550.05%
Atom Investors LP 18,522$68,5310.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$13,414,2280.03%
GSA CAPITAL PARTNERS LLP 21,514$800.01%
View complete list of PROQR THRAPEUTICS N V shareholders